-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Introduction The pathogenesis of hepatocellular carcinoma (HCC) in China mostly follows the "three-step" model of "hepatitis B-liver cirrhosis-liver cancer"
.
The screening of precancerous lesions has achieved remarkable results in the diagnosis and treatment of malignant tumors such as gastric cancer, colorectal cancer and cervical cancer
.
Based on the research results and clinical experience of experts in this field at home and abroad, the "Multidisciplinary Expert Consensus on the Diagnosis and Treatment of Hepatocellular Carcinoma Precancerous Lesions (2020 Edition)" has been coordinated to treat high-grade dysplastic nodules in the liver as liver cancer.
The precancerous lesions of liver cancer are summarized and defined in terms of concept, screening, diagnosis, treatment and follow-up.
The aim is to propose and establish the concept and principles of diagnosis and treatment of liver cancer precancerous lesions, in order to reduce the incidence of liver cancer in China and improve liver cancer.
Contribute to the overall therapeutic effect
.
This article summarizes the screening and diagnosis part of the consensus,